- Home
- SGMO vs MPU Comparison
SGMO vs MPU Comparison
Compare SGMO & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- MPU
- Stock Information
- Founded
- SGMO 1995
- MPU 1989
- Country
- SGMO United States
- MPU Singapore
- Employees
- SGMO N/A
- MPU N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- MPU Transportation Services
- Sector
- SGMO Health Care
- MPU Consumer Discretionary
- Exchange
- SGMO Nasdaq
- MPU Nasdaq
- Market Cap
- SGMO 122.8M
- MPU 117.8M
- IPO Year
- SGMO 2000
- MPU 1998
- Fundamental
- Price
- SGMO $0.51
- MPU $1.42
- Analyst Decision
- SGMO Strong Buy
- MPU
- Analyst Count
- SGMO 7
- MPU 0
- Target Price
- SGMO $5.29
- MPU N/A
- AVG Volume (30 Days)
- SGMO 5.2M
- MPU 1.2M
- Earning Date
- SGMO 08-07-2025
- MPU 09-19-2025
- Dividend Yield
- SGMO N/A
- MPU N/A
- EPS Growth
- SGMO N/A
- MPU N/A
- EPS
- SGMO N/A
- MPU N/A
- Revenue
- SGMO $81,706,000.00
- MPU $35,228,600.00
- Revenue This Year
- SGMO $21.24
- MPU N/A
- Revenue Next Year
- SGMO N/A
- MPU N/A
- P/E Ratio
- SGMO N/A
- MPU N/A
- Revenue Growth
- SGMO 565.52
- MPU 305.32
- 52 Week Low
- SGMO $0.41
- MPU $0.49
- 52 Week High
- SGMO $3.18
- MPU $4.44
- Technical
- Relative Strength Index (RSI)
- SGMO 44.92
- MPU 31.77
- Support Level
- SGMO $0.47
- MPU $1.24
- Resistance Level
- SGMO $0.56
- MPU $1.91
- Average True Range (ATR)
- SGMO 0.03
- MPU 0.34
- MACD
- SGMO -0.00
- MPU -0.16
- Stochastic Oscillator
- SGMO 32.31
- MPU 8.52
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.